Literature DB >> 2720322

Changes in the hepatic perfusion index during the development of experimental hepatic tumours.

D M Nott1, S J Grime, J Yates, D W Day, J N Baxter, S A Jenkins, T G Cooke.   

Abstract

A model of microscopic liver tumour has been developed in the Fisher rat by intraportal injection of 1.6 x 10(7) Walker 256 carcinosarcoma cells. Rats were studied at 2, 4 and 6 days after the inoculation of live Walker cells. A control group received dead Walker cells. No tumour was visible in control groups at 2, 4 and 6 days after inoculation. Similarly in rats injected with live cells no tumour was visible at 2 days after inoculation but at 4 and 6 days the percentage hepatic replacement was (mean +/- s.d.) 7.0 +/- 2.3 and 27.9 +/- 6.80 respectively. The hepatic perfusion index was significantly raised at 4 and 6 days after inoculation of live cells compared with control animals and those receiving viable cells after 2 days inoculation. Portal flow and portal venous inflow were significantly reduced when the hepatic perfusion index increased but hepatic arterial flow did not alter. Changes in the hepatic haemodynamics were accompanied by increases in the portal and splanchnic vascular resistance and an increase in the amount of arteriovenous shunting through the liver. These findings confirm studies that the hepatic perfusion index is useful in the detection of occult liver metastases but that the change is not a consequence of an increase in the hepatic arterial flow.

Entities:  

Mesh:

Year:  1989        PMID: 2720322     DOI: 10.1002/bjs.1800760315

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

1.  Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis.

Authors:  E Leen; J A Goldberg; J R Anderson; J Robertson; B Moule; T G Cooke; C S McArdle
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

2.  Hepatic portal venous flow in patients undergoing tricuspid valve surgery.

Authors:  S F Purkiss; S Fort; T R Graham; P G Mills; C T Lewis
Journal:  Br Heart J       Date:  1994-04

3.  Detection of hepatic metastases using duplex/color Doppler sonography.

Authors:  E Leen; J A Goldberg; J Robertson; G R Sutherland; D M Hemingway; T G Cooke; C S McArdle
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

Review 4.  Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation.

Authors:  Maka Kekelidze; Luigia D'Errico; Michele Pansini; Anthony Tyndall; Joachim Hohmann
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

5.  Preoperative hepatic CT perfusion as an early predictor for the recurrence of esophageal squamous cell carcinoma: initial clinical results.

Authors:  Takeshi Fujishiro; Kiyohiko Shuto; Koichi Hayano; Asami Satoh; Tsuguaki Kono; Gaku Ohira; Takayuki Tohma; Hisashi Gunji; Kazuo Narushima; Toru Tochigi; Toshiharu Hanaoka; Sayaka Ishii; Noriyuki Yanagawa; Hisahiro Matsubara
Journal:  Oncol Rep       Date:  2014-01-22       Impact factor: 3.906

6.  Changes in hepatic haemodynamics in rats with overt liver tumour.

Authors:  D M Nott; S J Grime; J Yates; J N Baxter; T G Cooke; S A Jenkins
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

7.  Splanchnic blood flow changes in the presence of hepatic tumour: evidence of a humoral mediator.

Authors:  R Carter; J H Anderson; T G Cooke; J N Baxter; W J Angerson
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

8.  The use of duplex sonography in the detection of colorectal hepatic metastases.

Authors:  E Leen; J A Goldberg; J Robertson; G R Sutherland; C S McArdle
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.